dc.description.abstract | An in vivo study was carried out to determine the effect of different types of Kenyan
tea extracts on male Swiss albino mice infected with Trypanosoma brucei brucei isolate
KETRI 2710. The isolate produced a similar clinical picture after a pre-patent period of
five days post-infection (DPI). Parasitemia levels in the untreated mice and those given
different tea developed exponentially at similar rates reaching the peak of parasitemia 8
DPI. Between 9 and 13 DPI parasitemia decreased more rapidly in tea treated compared
to the untreated mice which indicated that tea lowered parasitemia. Anaemia indicated
by a fall in erythrocyte packed cell volume (PCV) occurred within 4 DPI and remained
below the normal levels until the terminal stages of the disease. A significant difference (P
< 0.05) was observed 11 DPI between the tea treated and the untreated mice indicating
that tea enhanced resistance to erythrocyte destruction. Mice treated with tea exhibited
significantly (P < 0.01) reduced parasite induced hypoalbuminemia as compared to the
untreated demonstrating that tea ameliorated inflammation induced by T. brucei brucei.
Black tea, which is the principle tea product from Kenya, displayed remarkable properties
some even comparable to those of green tea. Tea was more efficacious than dexamethasone, an established anti-inflammatory drug, demonstrating its therapeutic potential. | en_US |